Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 4Active not recruiting 3Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Locally Advanced HER2-negative Breast Cancer 1Breast Neoplasms 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × AC protocol × Clear all
NCT02096588 2024-07-09

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
34 enrolled 11 charts
Breast

Breast Neoplasms

NCT01329627 2014-05-21

TAME-01

Instituto do Cancer do Estado de São Paulo

Phase 2 Terminated
12 enrolled
Breast

Locally Advanced HER2-negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡